Año: 2023
Journal Impact Factor (JIF): 9.50
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | 22/313 | Q1 | T1 | D1 |
| CELL BIOLOGY | SCIE | 27/205 | Q1 | T1 | D2 |
Año: 2023
Journal Citation Indicator (JCI): 1,710
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| BIOCHEMISTRY & MOLECULAR BIOLOGY | 21/313 | Q1 | T1 | D1 | 93,45 |
| CELL BIOLOGY | 22/205 | Q1 | T1 | D2 | 89,51 |
Año:
2023
CiteScore:
18,900
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (all) | 11/221 | Q1 | T1 | D1 |
| Immunology and Microbiology (all) | 3/61 | Q1 | T1 | D1 |
| Molecular Biology | 25/410 | Q1 | T1 | D1 |
| Neuroscience (all) | 6/113 | Q1 | T1 | D1 |
SJR año:
2023
Factor de Impacto:
5,489
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Biochemistry, Genetics and Molecular Biology (miscellaneous) | 8/304 | Q1 | T1 | D1 |
| Medicine (miscellaneous) | 27/2494 | Q1 | T1 | D1 |
| Molecular Biology | 15/422 | Q1 | T1 | D1 |
| Neuroscience (miscellaneous) | 6/154 | Q1 | T1 | D1 |
| Agencia | Código de Proyecto |
|---|---|
| EU | - |
| European Unionapos;s Horizon Europe Research and Innovation Programme | 965406; MR/V038966/1 |
| This research is mainly a product of the EOSC-Life European programme funding from the European Unionapos;s Horizon Europe Research and Innovation Programme under grant agreement No. 824087. Complementary support was provided through: EU funded project Ag | 824087 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | European Res Infrastruct Highly Pathogen Agents ER (Belgium) | |
| 2 | European Molecular Biology Laboratory (EMBL) (Germany) | |
| 3 | University of Dundee (Scotland) | |
| 4 | European Molecular Biology Laboratory (EMBL) (Germany) | |
| 5 | Audergon, P | Instruct ERIC (England) |
| 6 | Boiten, JW | European Adv Translat Res Infrastruct EATRIS Lygat (Netherlands) |
| 7 | Coppens, F | Ghent University (Belgium) |
| 8 | Crockett, S | BBMRI ERIC (Austria) |
| 9 | Exter, K | Flanders Marine Inst (Belgium) |
| 10 | Fahrner, S | Research Center Julich (Germany) |
| 11 | Fratelli, M | Istituto di Ricerche Farmacologiche Mario Negri IRCCS (Italy) |
| 12 | Goble, C | University of Manchester (England) |
| 13 | Gormanns, P | INFRAFRONTIER (Germany) |
| 14 | Grantner, T | Technische Universitat Wien (Austria) |
| 15 | Grüning, B | Albert Ludwigs Univ Freiburg Freiburg (Germany) |
| 16 | Gurwitz, KT | European Molecular Biology Laboratory (EMBL) (England) |
| 17 | Hancock, JM | Sin datos () |
| 18 | Harmse, H | European Molecular Biology Laboratory (EMBL) (England) |
| 19 | Holub, P | BBMRI ERIC (Austria) |
| 20 | Juty, N | University of Manchester (England) |
| 21 | Karnbach, G | Technische Universitat Wien (Austria) |
| 22 | Karoune, E | Hist England (England) |
| 23 | Keppler, A | European Molecular Biology Laboratory (EMBL) (Germany) |
| 24 | Lancelotti, C | Pompeu Fabra University (Spain) |
| 25 | Klemeier, J | European Molecular Biology Laboratory (EMBL) (Germany) |
| 26 | Legras, JL | Institut Agro (France) |
| 27 | Lister, AL | University of Oxford (England) |
| 28 | Longo, DL | Istituto di Biostrutture e Bioimmagini (IBB-CNR) (Italy) |
| 29 | Ludwig, R | Vrije Universiteit Amsterdam (Netherlands) |
| 30 | Madon, B | Universidad de Sevilla (Spain) |
| 31 | Massimi, M | Consiglio Nazl Ric CNR (Italy) |
| 32 | Matser, V | Alan Turing Inst (England) |
| 33 | Matteoni, R | Consiglio Nazl Ric CNR (Italy) |
| 34 | Mayrhofer, MT | Sin datos () |
| 35 | Ohmann, C | European Clin Res Infrastruct Network ECRIN (Germany) |
| 36 | Panagiotopoulou, M | European Clin Res Infrastruct Network ECRIN (Germany) |
| 37 | Parkinson, H | European Molecular Biology Laboratory (EMBL) (England) |
| 38 | Perseil, I | Institut National de la Sante et de la Recherche Medicale (Inserm) (France) |
| 39 | Pfander, C | European Molecular Biology Laboratory (EMBL) (Germany) |
| 40 | Pieruschka, R | Research Center Julich (Germany) |
| 41 | Raess, M | INFRAFRONTIER GmbH Neuherberg Munchen (Germany) |
| 42 | Rauber, A | Technische Universitat Wien (Austria) |
| 43 | Richard, AS | European Res Infrastruct Highly Pathogen Agents ER (Belgium) |
| 44 | Romano, P | IRCCS Osped Policlin San Martino (Italy) |
| 45 | Rosato, A | University of Florence (Italy) |
| 46 | Sanchez-Pla, A | University of Barcelona (Spain) |
| 47 | Sansone, SA | University of Oxford (England) |
| 48 | Sarkans, U | European Molecular Biology Laboratory (EMBL) (England) |
| 49 | Serrano-Solano, B | European Molecular Biology Laboratory (EMBL) (Germany) |
| 50 | Tang, J | University of Helsinki (Finland) |
| 51 | Tanoli, Z | University of Helsinki Institute for Molecular Medicine Finland (Finland) |
| 52 | Tedds, J | ELIXIR Hub (England) |
| 53 | Wagener, H | BIH Charite Univ Med Berlin (Germany) |
| 54 | Weise, M | Technische Universitat Wien (Austria) |
| 55 | Westerhoff, H | Vrije Universiteit Amsterdam; University of Amsterdam; Univ Manchester (Netherlands) |
| 56 | Wittner, R | BBMRI ERIC (Austria) |
| 57 | European Res Infrastruct Highly Pathogen Agents ER (Belgium) | |
| 58 | ELIXIR Hub (England) | |
| 59 | ITMP Drug Discovery (Germany) |
